• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自体精液脱敏疗法治疗两名荷兰白种男性:在后射精期疾病综合征(POIS;第 2 部分)中的有益效果。

Hyposensitization therapy with autologous semen in two Dutch caucasian males: beneficial effects in Postorgasmic Illness Syndrome (POIS; Part 2).

机构信息

Department of Psychiatry and Neurosexology, HagaHospital, The Hague, The Netherlands.

出版信息

J Sex Med. 2011 Apr;8(4):1171-6. doi: 10.1111/j.1743-6109.2010.02167.x. Epub 2011 Jan 17.

DOI:10.1111/j.1743-6109.2010.02167.x
PMID:21241454
Abstract

INTRODUCTION

Postorgasmic illness syndrome (POIS) is a post-ejaculatory complex of local and/or systemic symptoms that nearly always occurs within seconds, minutes, or hours post-masturbation, coitus, or spontaneous ejaculation. Recent data suggest an autoimmunogenic/allergic underlying mechanism.

AIM

To treat males with POIS by hyposensitization with their own semen (autologous semen).

METHODS

Two males suffering from POIS, of which one male with coincidental lifelong premature ejaculation (PE) were investigated. Based on their local and systemic symptoms including a positive dermatologic reaction after skin-prick testing with autologous semen, auto-allergy to semen was likely an underlying mechanism. A hyposensitization program was initiated, including multiple subcutaneous (SC) injections with autologous semen, initially at 2 weeks intervals in the first year and gradually at 4 weeks intervals in the second and third year. From initial semen dilutions of 1 on 40,000 and 1 on 20,000, the titers were gradually increased to 1 on 20 and 1 to 280, respectively.

MAIN OUTCOME MEASURES

Evaluation with a dedicated questionnaire about severity of POIS symptoms and specialized interviews on self-perceived intravaginal ejaculation latency times (IELT) before and during the desensitization program.

RESULTS

POIS was confirmed in both subjects, PE was confirmed in one male, and skin-prick tests with autologous semen in both subjects were positive. During the program, gradual reduction of complaints resulted in 60% and 90% amelioration of POIS complaints at 31 and 15 months, respectively, which coincided in one male with a delay of the IELT from 20 seconds at baseline to 10 minutes after 3 years of treatment. The cause of this association with IELT is unknown and remains to be elucidated.

CONCLUSIONS

Two males with POIS were successfully treated by hyposensitization with autologous semen, which supports an immunogenic/allergic etiology and underscores the clinical implication for immunological sexual medicine.

摘要

简介

射精后疾病综合征(POIS)是一种在自慰、性交或自发性射精后数秒、数分钟或数小时内出现的局部和/或全身症状的综合征。最近的数据表明,其潜在机制可能与自身免疫/过敏有关。

目的

通过对自身精液(自体精液)进行低敏化治疗来治疗 POIS 男性患者。

方法

对两名患有 POIS 的男性患者进行了研究,其中一名男性还伴有终生早泄(PE)。根据他们的局部和全身症状,包括自体精液皮试后的阳性皮肤反应,推测精液自身过敏可能是其潜在机制。启动了低敏化方案,包括多次自体精液皮下(SC)注射,最初在第一年每 2 周一次,然后在第二年和第三年逐渐每 4 周一次。初始精液稀释度分别为 1:40,000 和 1:20,000,滴度逐渐增加至 1:20 和 1:280。

主要观察指标

使用专门的问卷评估 POIS 症状的严重程度,并在脱敏治疗前后对自我感知的阴道内射精潜伏期时间(IELT)进行专门访谈。

结果

两名患者均确诊为 POIS,一名患者确诊为 PE,两名患者的自体精液皮试均为阳性。在治疗过程中,随着时间的推移,症状逐渐减轻,31 个月和 15 个月时 POIS 症状分别改善了 60%和 90%,其中一名患者的 IELT 也从基线时的 20 秒延迟至 3 年后的 10 分钟。这种与 IELT 的关联的原因尚不清楚,仍需进一步阐明。

结论

两名 POIS 男性患者通过自体精液低敏化治疗取得了成功,这支持了免疫原性/过敏病因,并突出了免疫性性医学的临床意义。

相似文献

1
Hyposensitization therapy with autologous semen in two Dutch caucasian males: beneficial effects in Postorgasmic Illness Syndrome (POIS; Part 2).自体精液脱敏疗法治疗两名荷兰白种男性:在后射精期疾病综合征(POIS;第 2 部分)中的有益效果。
J Sex Med. 2011 Apr;8(4):1171-6. doi: 10.1111/j.1743-6109.2010.02167.x. Epub 2011 Jan 17.
2
Postorgasmic Illness Syndrome (POIS) in 45 Dutch caucasian males: clinical characteristics and evidence for an immunogenic pathogenesis (Part 1).45 名荷兰白种男性中的 postorgasmic illness syndrome (POIS):临床特征和免疫发病机制的证据(第 1 部分)。
J Sex Med. 2011 Apr;8(4):1164-70. doi: 10.1111/j.1743-6109.2010.02166.x. Epub 2011 Jan 17.
3
Postorgasmic illness syndrome (POIS) in a Chinese man: no proof for IgE-mediated allergy to semen.一名中国男性的性高潮后疾病综合征(POIS):无IgE介导的精液过敏证据
J Sex Med. 2015 Mar;12(3):840-5. doi: 10.1111/jsm.12813. Epub 2015 Jan 29.
4
Post-Orgasmic Illness Syndrome: A Review.性高潮后疾病综合征:综述。
Sex Med Rev. 2018 Jan;6(1):11-15. doi: 10.1016/j.sxmr.2017.08.006. Epub 2017 Nov 8.
5
Clinical characteristics, allergic response to autologous semen, and desensitization in patients with postorgasmic illness syndrome.性高潮后疾病综合征患者的临床特征、对自身精液的过敏反应及脱敏治疗
Sex Med. 2024 Jan 17;11(6):qfad068. doi: 10.1093/sexmed/qfad068. eCollection 2023 Dec.
6
Negative allergy study in a case of postorgasmic illness syndrome (POIS).一例性高潮后疾病综合征(POIS)患者的过敏阴性研究。
Rev Int Androl. 2018 Jan-Mar;16(1):42-44. doi: 10.1016/j.androl.2017.06.002. Epub 2017 Oct 10.
7
Premature ejaculation: bother and intravaginal ejaculatory latency time in Iran.早泄:伊朗的困扰和阴道内射精潜伏时间。
J Sex Med. 2009 Dec;6(12):3478-89. doi: 10.1111/j.1743-6109.2009.01468.x. Epub 2009 Aug 28.
8
Intensified Hyposensitization Is an Effective Treatment of Postorgasmic Illness Syndrome (POIS).强化脱敏疗法是治疗性高潮后疾病综合征(POIS)的有效方法。
Sex Med. 2022 Apr;10(2):100474. doi: 10.1016/j.esxm.2021.100474. Epub 2022 Jan 15.
9
Postorgasmic Illness Syndrome: An Update.性后疾病综合征:最新进展。
Eur Urol Focus. 2023 Jan;9(1):22-24. doi: 10.1016/j.euf.2022.09.016. Epub 2022 Oct 22.
10
Intralymphatic Immunotherapy With Autologous Semen in a Korean Man With Post-Orgasmic Illness Syndrome.对一名患有性高潮后疾病综合征的韩国男性进行自体精液淋巴内免疫疗法。
Sex Med. 2018 Jun;6(2):174-179. doi: 10.1016/j.esxm.2017.12.004. Epub 2018 Mar 15.

引用本文的文献

1
A Role for IgE in Post-Orgasmic Illness Syndrome: Successful Omalizumab Treatment in Absence of Positive Skin Test to Self Semen.IgE在性高潮后疾病综合征中的作用:在对自身精液皮肤试验阴性的情况下,奥马珠单抗治疗成功
Am J Case Rep. 2025 Feb 2;26:e945529. doi: 10.12659/AJCR.945529.
2
Postorgasmic illness syndrome benefiting from omalizumab and antidepressant: a case report.奥马珠单抗和抗抑郁药治疗后性疾病综合征:一例报告
J Med Case Rep. 2024 Dec 21;18(1):632. doi: 10.1186/s13256-024-04986-2.
3
Clinical characteristics, allergic response to autologous semen, and desensitization in patients with postorgasmic illness syndrome.
性高潮后疾病综合征患者的临床特征、对自身精液的过敏反应及脱敏治疗
Sex Med. 2024 Jan 17;11(6):qfad068. doi: 10.1093/sexmed/qfad068. eCollection 2023 Dec.
4
A clinical guide to rare male sexual disorders.男性罕见性障碍临床指南。
Nat Rev Urol. 2024 Jan;21(1):35-49. doi: 10.1038/s41585-023-00803-5. Epub 2023 Sep 5.
5
Recognition and practice patterns of sexual medicine experts towards postorgasmic illness syndrome.性医学专家对性高潮后疾病综合征的认知与实践模式
Int J Impot Res. 2023 Aug 21. doi: 10.1038/s41443-023-00753-x.
6
Case series: expanding diagnostic markers in postorgasmic illness syndrome.病例系列:后性高潮疾病综合征中不断扩展的诊断标志物
Sex Med. 2023 Mar 2;11(2):qfac021. doi: 10.1093/sexmed/qfac021. eCollection 2023 Apr.
7
Post orgasmic illness syndrome successfully managed with antihistamine: A case report.用抗组胺药成功治疗性高潮后疾病综合征:一例报告
Urol Case Rep. 2022 Aug 18;45:102189. doi: 10.1016/j.eucr.2022.102189. eCollection 2022 Nov.
8
Intensified Hyposensitization Is an Effective Treatment of Postorgasmic Illness Syndrome (POIS).强化脱敏疗法是治疗性高潮后疾病综合征(POIS)的有效方法。
Sex Med. 2022 Apr;10(2):100474. doi: 10.1016/j.esxm.2021.100474. Epub 2022 Jan 15.
9
The first Tunisian case of postorgasmic illness syndrome: A case report.突尼斯首例性高潮后疾病综合征病例报告
Clin Case Rep. 2021 Nov 19;9(11):e05120. doi: 10.1002/ccr3.5120. eCollection 2021 Nov.
10
Novel treatment for post-orgasmic illness syndrome: a case report and literature review.性高潮后疾病综合征的新型治疗方法:一例病例报告及文献综述
Asian J Androl. 2022 May-Jun;24(3):332-334. doi: 10.4103/aja202170.